BL
Belite Bio, Inc (BLTE)
NASDAQ·Healthcare·Biotechnology
$147.43
+1.17%
Mkt Cap $6.72B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (17 analysts)
$238.33
Range $206.00 – $303.00
Implied Upside
+61.7%
Consensus $238.33 vs current $147.43
NASDAQ·Healthcare·Biotechnology
$147.43
+1.17%
Mkt Cap $6.72B
Buy
3
Hold
0
Sell
0
Price Target (17 analysts)
$238.33
Range $206.00 – $303.00
+61.7%
Consensus $238.33 vs current $147.43